Skip to main content
ConductScienceScienceDex

Scampavia, Louis Daniel

From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.

FY2021 NIH rank #15,421
Unclaimed recordClaim profile
  • Rising Star
  • R01 Holder

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2003 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2021 award categories

  • Pharmacology

NIH Funding · FY2021

Linked Award Amount
$682.2K
Full award amounts, FY2021
Award Records
2
Records listing this PI
Award-Linked Rank
#15,421
By linked amount among FY2021 PIs
Earliest Year Loaded
2003
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Scampavia, Louis Daniel. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2021 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2021 award records by amount

NIH award records listing Scampavia, Louis Daniel as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA241816-03R01Contact PI
    Identification of REV-ERB inverse agonists for cancer immunotherapy
    Scripps Florida
    $392.6K
    award amount
  • 6R01CA241816-04R01Contact PI
    Identification of REV-ERB inverse agonists for cancer immunotherapy
    University of Florida · Pharmacology (NIH department code)
    $289.6K
    award amount

Award organizations

Organizations that administered FY2021 awards listing Scampavia, Louis Daniel as a PI.

Scripps Florida
$392.6K
1 grant
University of Florida
FL
$289.6K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2003
    First NIH Award
    Scripps Florida
  2. 2018
    $500K Cumulative Funding
  3. 2018
    Multi-Institutional Research
    Awards at 2 institutions
  4. 2018
    R01 Grant Holder
  5. 2019
    $1M Cumulative Funding
  6. 2019
    Entered Top 50% Nationally
    Ranked #7417
  7. 2020
    $2M Cumulative Funding
  8. 2020
    Entered Top 25% Nationally
    Ranked #2425

Explore further

Find collaborators for Scampavia, Louis Daniel

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →